Literature DB >> 8704029

Distribution of prolyl oligopeptidase in human peripheral tissues and body fluids.

F Goossens1, I De Meester, G Vanhoof, S Scharpé.   

Abstract

Prolyl oligopeptidase (EC 3.4.21.26) activity was measured in human tissue homogenates and body fluids. The enzyme was ubiquitously present, revealing high activity in renal cortex, epithelial cells, fibroblasts, testis, lymphocytes and thrombocytes. The activity in the body fluids was low. Prolyl oligopeptidase activity was significant higher in tumours of prostate, lung and sigmoid, than in the healthy tissues. Sera of individuals suffering from HIV infection, malaria, prostate cancer or benign prostate hypertrophy contained lowered activity. Interestingly, the low serum activity during prostate carcinoma increased upon medical treatment with anti-androgens. This suggests hormonal control of the gene transcript. A positive correlation with angiotensin converting enzyme activity in hypertensive patients was demonstrated and this further supports the possible involvement of prolyl oligopeptidase in the renin-angiotensin system and in the pathogenesis of hypertension.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8704029     DOI: 10.1515/cclm.1996.34.1.17

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  31 in total

1.  ENPDA: an evolutionary structure-based de novo peptide design algorithm.

Authors:  Ignasi Belda; Sergio Madurga; Xavier Llorà; Marc Martinell; Teresa Tarragó; Mireia G Piqueras; Ernesto Nicolás; Ernest Giralt
Journal:  J Comput Aided Mol Des       Date:  2005-11-03       Impact factor: 3.686

2.  Renal release of N-acetyl-seryl-aspartyl-lysyl-proline is part of an antifibrotic peptidergic system in the kidney.

Authors:  Cesar A Romero; Nitin Kumar; Pablo Nakagawa; Morel E Worou; Tang-Dong Liao; Edward L Peterson; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2018-11-07

3.  Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen.

Authors:  Philip J O'Reilly; Matthew T Hardison; Patricia L Jackson; Xin Xu; Robert J Snelgrove; Amit Gaggar; F Shawn Galin; J Edwin Blalock
Journal:  J Neuroimmunol       Date:  2009-10-28       Impact factor: 3.478

4.  Tetrazole as a Replacement of the Electrophilic Group in Characteristic Prolyl Oligopeptidase Inhibitors.

Authors:  Tommi P Kilpeläinen; Jonna K Tyni; Maija K Lahtela-Kakkonen; Tony S Eteläinen; Timo T Myöhänen; Erik A A Wallén
Journal:  ACS Med Chem Lett       Date:  2019-11-11       Impact factor: 4.345

5.  Brain prolyl endopeptidase expression in aging, APP transgenic mice and Alzheimer's disease.

Authors:  Steffen Rossner; Ingo Schulz; Ulrike Zeitschel; Reinhard Schliebs; Volker Bigl; Hans-Ulrich Demuth
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

6.  Increased angiotensin II-induced hypertension and inflammatory cytokines in mice lacking angiotensin-converting enzyme N domain activity.

Authors:  Frank S Ong; Chentao X Lin; Duncan J Campbell; Derick Okwan-Duodu; Xu Chen; Wendell-Lamar B Blackwell; Kandarp H Shah; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Kenneth E Bernstein
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

7.  MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition.

Authors:  Daniela Macconi; Susanna Tomasoni; Paola Romagnani; Piera Trionfini; Fabio Sangalli; Benedetta Mazzinghi; Paola Rizzo; Elena Lazzeri; Mauro Abbate; Giuseppe Remuzzi; Ariela Benigni
Journal:  J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 10.121

8.  Distribution of immunoreactive prolyl oligopeptidase in human and rat brain.

Authors:  Timo T Myöhänen; Jarkko I Venäläinen; Erkki Tupala; J Arturo Garcia-Horsman; Riitta Miettinen; Pekka T Männistö
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

9.  Distribution of prolyl oligopeptidase in human peripheral tissues and in ovarian and colorectal tumors.

Authors:  Timo T Myöhänen; Elisa Pyykkö; Pekka T Männistö; Olli Carpen
Journal:  J Histochem Cytochem       Date:  2012-06-26       Impact factor: 2.479

10.  Distribution of prolyl oligopeptidase in the mouse whole-body sections and peripheral tissues.

Authors:  Timo T Myöhänen; Jarkko I Venäläinen; J Arturo García-Horsman; Marjo Piltonen; Pekka T Männistö
Journal:  Histochem Cell Biol       Date:  2008-07-11       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.